Mounjaro side effects as a weight loss drug: what to expect

The most common side effects are gut-related: nausea, loose stools, constipation, indigestion and burping are all reported in clinical trial data and in the NHS tirzepatide patient guide.
Most GI symptoms are at their worst after starting or increasing a dose and typically ease within days to two weeks as your body adjusts.
Serious but infrequent effects exist, including acute pancreatitis: the MHRA highlighted this risk in a Drug Safety Update in January 2026 and sets out which symptoms need urgent attention.
Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme, and our prescribers are available seven days a week if something concerns you during treatment.

Mounjaro (tirzepatide) causes side effects in most people who take it for weight loss, and the majority are gastrointestinal. Nausea is the most commonly reported, affecting roughly half of participants in clinical trials; it tends to peak in the first few weeks at each dose level, then settle. Understanding what's typical, what passes quickly, and what needs prompt medical attention lets you approach treatment with clear eyes. As a prescription-only medicine, Mounjaro is only available following clinical assessment by a registered prescriber, who will discuss your individual risk profile before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A clear breakdown of Mounjaro's side effects during weight loss treatment

Which side effects do most people actually experience on Mounjaro?

The honest starting point is that most people on tirzepatide for weight loss notice some digestive disruption, particularly in the first few weeks. Nausea is the headline, but the fuller picture from the SURMOUNT-1 trial includes vomiting, diarrhoea, constipation, acid reflux, burping, and stomach discomfort at varying frequencies. Fatigue and headache appear less often, as do dizziness and injection-site reactions (redness, mild swelling, itching at the injection point).

The pattern matters as much as the list. Symptoms tend to spike after each dose step upward, which is why the prescribing schedule starts at the lowest strength and moves gradually. Many people report that nausea is noticeable on injection day and the day after, then fades. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all reduce the burden for most people. The full breakdown of Mounjaro's side effects for weight loss covers practical management tips in more detail.

One practical note on routine: keeping your pen in the fridge door and injecting on the same day each week helps turn it into a habit rather than a decision, which in turn makes it easier to track any pattern in how you feel afterwards.

Are there side effects that need urgent medical attention?

Yes. Several effects are infrequent but serious, and knowing them in advance is part of taking the medicine safely.

Acute pancreatitis is the most significant. In January 2026 the MHRA issued a Drug Safety Update emphasising that GLP-1 medicines, including tirzepatide, carry a known risk of acute pancreatitis. The warning signs are severe, persistent stomach pain that may spread toward your back, sometimes accompanied by vomiting. This is not ordinary nausea. If you experience it, stop eating, seek urgent medical care, and tell the clinician you are taking tirzepatide. You can also report it via the Yellow Card scheme.

Gallbladder problems are also associated with rapid weight loss generally and with GLP-1 medicines specifically. Sudden pain in the upper right abdomen, particularly after eating, warrants a call to your GP or 111.

Allergic reactions are rare but possible: facial swelling, breathing difficulty, or a widespread rash need emergency attention.

Severe dehydration can develop if vomiting or diarrhoea is prolonged. Signs include dizziness on standing, very dark urine, and inability to keep fluids down. Call 111 or see a GP. Full safety context, including less common effects, is covered on the Mounjaro safety overview.

Do Mounjaro's side effects change over time, and do they go away?

For most people, the worst of the GI symptoms belong to the early weeks. Once the body has adapted to a given dose, nausea, loose stools and fatigue commonly reduce or disappear before the next scheduled dose increase. Some people find they return briefly at each new strength, then settle again.

A smaller proportion of people continue to experience nausea throughout treatment. In those cases, prescribers may slow the titration pace or discuss whether the medicine remains the right fit. The long-term side effects of tirzepatide are an active area of monitoring given the medicine's Black Triangle (▼) status with the MHRA, which means ongoing post-authorisation safety studies are in place.

Muscle loss is occasionally raised as a concern. Rapid weight loss from any cause can reduce lean mass alongside fat; adequate protein and resistance exercise are the standard advice from prescribers and dietitians for people on treatment. This is worth discussing during your consultation, not something to self-manage in isolation.

The tirzepatide-specific side-effect data drawn from the SURMOUNT programme gives more granular figures for those who want them.

How does the consultation at nume address side effects?

Before a prescription is issued, a GPhC-registered Independent Prescriber reviews your health information personally. That review considers your full medical history, current medicines, and any factors that raise your individual risk — pancreatitis history and certain gastrointestinal conditions, for instance, affect whether Mounjaro is appropriate at all.

Side effects are not an afterthought in that conversation. The prescriber looks at your profile and can advise on which symptoms are worth monitoring closely in your case. After treatment starts, our clinical team is available seven days a week if something changes or a symptom concerns you — not just at the next repeat review. You can also read accounts from people who have been through the titration process on the Mounjaro reviews and side effects page, which keeps the picture honest rather than selective.

If you want to understand your options across all available treatments before committing, the weight loss treatment overview sets out the full picture. When you are ready, our prescribers discuss suitability and side effects as part of every free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions